Drug Delivery

Apr 01, 2015
BioPharm International
Second-generation needle-free injection systems will make parenteral drug administration more convenient, efficient, and safe.
Apr 01, 2015
BioPharm International
Ethylene vinyl acetate (EVA) drug-release technologies are explored.
Mar 06, 2015
The agency will employ a ring vaccination method similar to the one used to eradicate smallpox.
Feb 04, 2015
Sanofi launched a rapidly absorbed, short-acting inhalable insulin in the US to help control type 1 and type 2 diabetes.
Feb 03, 2015
By BioPharm International Editors
Mylan announced a partnership with Theravance Biopharma to develop and commercialize TD-4208, a novel investigational COPD treatment.
Jan 15, 2015
BioPharm International
By BioPharm International Editors
Catalent Pharma Solutions and Sanofi-Aventis R&D have entered into a collaboration to develop Sanofi’s proprietary antibodies using Catalent’s SMARTag antibody drug conjugate (ADC) platform.
Jan 01, 2015
BioPharm International
Ligand-binding assays are fundamental to characterizing biosimilars.
Dec 17, 2014
BioPharm International
Halozyme will receive an initial payment of $15 million for Enhanze, its technology that enables biologics to be delivered as a simple subcutaneous injection.
Dec 01, 2014
Applied Clinical Trials
The promise is that customized delivery of injectible drugs and biologics will reduce toxicity, enhance individual response, facilitate the delivery of multiple drugs, minimize waste, and encourage patient adherence to prescribed treatment.
Nov 25, 2014
By BioPharm International Editors
Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.
native1_300x100
lorem ipsum